Business Standard

Sunday, February 16, 2025 | 05:10 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Steady heartbeat of growth in diagnostics stock keeps sector pulsing

Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year

Heartbeat
Premium

IIFL Research also expects similar organic revenue growth (12-13 per cent) for Dr Lal PathLabs and Metropolis over FY25-27 (File Image)

Ram Prasad Sahu Mumbai

Listen to This Article

The stocks of diagnostic service providers have been standout performers within the healthcare sector over the past year, posting returns between 16 and 80 per cent. In comparison, the Nifty 50 saw returns of 8 per cent. Stable pricing, expectations of gradual volume growth, and market share expansion for the larger players have stoked increased optimism for listed companies.
 
Some of the expected operational gains could materialise in the October-December or January-March quarters of 2024-25 (FY25). The three largest listed players — Dr Lal PathLabs, Metropolis Healthcare, and Vijaya Diagnostic Centre — are expected to report a 14 per cent

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in